Hori Toshiyuki
Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Japan.
Cancers (Basel). 2024 Sep 9;16(17):3109. doi: 10.3390/cancers16173109.
Even if its completed form is complex, cancer originates from one or two events that happened to a single cell. A simplified model can play a role in understanding how cancer initiates at the beginning. The pathophysiology of leukemia has been studied in the most detailed manner among all human cancers. In this review, based on milestone papers and the latest research developments in hematology, acute promyelocytic leukemia (APL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML) with RUNX1-RUNX1T1 are selected to consider minimal requirements for cancer initiation. A one-hit model can be applied to the initiation of APL and CML whereas a two-hit model is more suitable to the initiation of AML with RUNX1-RUNX1T1 and other AMLs. Even in cancer cells with multiple genetic abnormalities, there must be a few mutant genes critical for the mutant clone to survive and proliferate. Such genes should be identified and characterized in each case in order to develop individualized target therapy.
即使癌症的完整形式很复杂,但它起源于单个细胞发生的一两个事件。一个简化模型有助于理解癌症最初是如何发生的。在所有人类癌症中,白血病的病理生理学研究最为详尽。在本综述中,基于里程碑式的论文以及血液学的最新研究进展,选取急性早幼粒细胞白血病(APL)、慢性粒细胞白血病(CML)以及伴有RUNX1-RUNX1T1的急性髓系白血病(AML)来探讨癌症发生的最低要求。单打击模型可应用于APL和CML的起始,而双打击模型更适用于伴有RUNX1-RUNX1T1的AML及其他AML的起始。即使在具有多种基因异常的癌细胞中,也必定存在一些对突变克隆的存活和增殖至关重要的突变基因。为了开发个体化的靶向治疗,每种情况下都应识别并表征这些基因。